or Try an Advanced Search...

    Treatment Of Migraine Stocks List

    Symbol Grade Name % Change
    ABBV B AbbVie Inc. -0.34
    AMRX D Amneal Pharmaceuticals, Inc. 0.06
    ASRT F Assertio Therapeutics, Inc. 3.00
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Migraine Pharmaceutical Acute Pain Adalimumab Advanced Prostate Cancer Amino Acids Analgesics Anemia Atopic Dermatitis Autoimmune Disease Blood Cancers Chemical Compounds Chronic Idiopathic Constipation Combination Drugs Constipation Crohn's Disease Depressive Disorder Diabetic Peripheral Neuropathy Drug Products Drugs

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Migraine stocks.

    Symbol Grade Name Weight
    HDLB B ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 9.8
    BOTZ B Global X Robotics & Artificial Intelligence Thematic ETF 9.28
    PJP B PowerShares Dynamic Pharmaceuticals 9.09
    MEDX F Horizon Kinetics Medical ETF 8.78
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 8.2
    View all Treatment Of Migraine ETFs...
    Compare ETFs
    Compare HDLB to BOTZ Compare HDLB to PJP Compare MEDX to FTXH

        Treatment Of Migraine Stocks Recent News

        Date Stock Title
        Nov 7 ABBV Allergan Aesthetics Celebrates Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day
        Nov 6 ABBV What the Options Market Tells Us About AbbVie
        Nov 6 ABBV Top 20 biopharmas’ market cap rises 2% in Q3 2024 amid flurry of drug approvals
        Nov 5 ABBV Is Most-Watched Stock AbbVie Inc. (ABBV) Worth Betting on Now?
        Nov 5 ABBV Should We Be Delighted With AbbVie Inc.'s (NYSE:ABBV) ROE Of 75%?
        Nov 5 ABBV Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight
        Nov 4 ABBV Is AbbVie Inc. (ABBV) the Best Pharma Stock to Buy Right Now?
        Nov 4 ABBV Dividend Investor Who Started 'Homeless and Penniless' Now Earns $4,800 a Month, Reveals Top 5 Stock Holdings
        Nov 2 ABBV M&A deals roundup: AbbVie, Blackstone, Take-Two Interactive and more
        Nov 2 ABBV 58-Year-Old Retiree Living Off Dividends Shares His Portfolio: Top 12 Stocks, ETFs
        Nov 1 ABBV Bristol Myers Squibb Stock Gets Relative Strength Rating Upgrade
        Nov 1 ABBV Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY's Q3 Earnings in Focus
        Nov 1 ABBV AbbVie Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        Nov 1 ABBV AbbVie and EvolveImmune Therapeutics sign oncology collaboration
        Nov 1 ABBV 5 Stocks That Recently Announced Dividend Hikes
        Nov 1 ABBV Regeneron battles Wall Street uncertainty; Madrigal extends fast launch of MASH drug
        Nov 1 ABBV Eli Lilly's Zepbound sales, Pfizer wants in on weight loss drugs, AbbVie's big deal: Pharma news round up
        Related Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Migraine Pharmaceutical Acute Pain Adalimumab Advanced Prostate Cancer Amino Acids Analgesics Anemia Atopic Dermatitis Autoimmune Disease Blood Cancers Chemical Compounds Chronic Idiopathic Constipation Combination Drugs Constipation Crohn's Disease Depressive Disorder Diabetic Peripheral Neuropathy Drug Products Drugs
        Treatment Of Migraine

        Treatment of migraine typically involves medications to reduce the intensity of the headache and prevent future attacks. Medications used to treat migraine include triptans, nonsteroidal anti-inflammatory drugs (NSAIDs), antiemetics, and anticonvulsants. Other treatments may include lifestyle modifications, such as avoiding triggers, stress management, and relaxation techniques. In some cases, preventive medications may be prescribed to reduce the frequency and severity of migraine attacks.

        Browse All Tags